Biological Therapies in Psychiatry Newsletter

- OR -

If you are
completing
your
residency and
received a
promotional
mailing,
enter your
code HERE

IN THIS MONTH'S ISSUE:

February 2010

Second-Generation Antipsychotics: New Information
Second-generation antipsychotics differ from each other, offering options for patients.

Cognitive Effects of Antipsychotic Drugs: Are All Created Equal?
First- and second-generation antipsychotics appear comparable in their ability to lessen cognitive dysfunction associated with schizophrenia.

In Brief
Long-acting Injectable Olanzapine Approved in US; High-potency Cannabis May Increase Risk of Psychosis

Olanzapine and Sertraline Combined for Psychotic Depression
In a short-term trial, sertraline (Zoloft and others) combined with olanzapine (Zyprexa) was more efficacious than olanzapine plus placebo for psychotic depression in both young and elderly patients.

"With time as tight as it is, I really appreciate the sheer volume of material that you review and summarize for us. You provide a tremendous service to busy clinicians like me and those we serve. Thanks again!"

- J. Rutherford, M.D.

PO Box 42650, Tucson, AZ 85733-2650 • Phone 1-800-700-9589(US) or 1-520-572-2039 (Outside US) • Fax 1-520-825-3793 • Email information@btpnews.com
Contents of entire Website and Biological Therapies in Psychiatry Newsletter are ©2010 Gelenberg Consulting & Publishing All rights are reserved. Any unauthorized reproduction constitutes a violation of federal law.

Disclaimer: This publication provides general coverage of its subject area. It is sold with the understanding that the authors and publisher are not engaged in rendering medical or other professional advice or services. If medical or other expert advice is required, a competent professional should be consulted. The authors and publisher shall not be responsible for any damages resulting from any error, inaccuracy, or omission contained in this publication.